Andrew Saik's Trading History
| ARVNArvinas Holding Company | Jun 24, 2026 | CFO | Informative Sell | 46.42K | $1.47M | |
| ICPTIntercept Pharma | Sep 25, 2023 | ― | Uninformative Sell | 9.81K | $1.30M | |
| YARWYarrow Bioscience | Jun 02, 2021 | CFO | Uninformative Buy | 10.11K | $2.32M | |
| PDSBPDS Biotechnology | Feb 19, 2020 | CFO, Director | Uninformative Buy | 49.92K | $61.27K | |
| AUXLAuxilium | Jan 30, 2015 | ― | Uninformative Sell | 365.30K | ― | |
| MISTMilestone Pharmaceuticals | ― | Director | ― | ― |
You May Also Like
Andrew Saik insider profile FAQ
What is the percentage of profitable transactions made by Andrew Saik?
The percentage of profitable transactions made by Andrew Saik is 60%.
What is the average return per transaction made by Andrew Saik?
The average return per transaction made by Andrew Saik is -4.10%.
What stocks does Andrew Saik hold?
Andrew Saik holds: ARVN, AUXL, ICPT, PDSB, YARW, MIST stocks.
What was Andrew Saik’s latest transaction?
Andrew Saik’s latest transaction was an Informative Sell of $46.42K.
What was Andrew Saik's most profitable transaction?
Andrew Saik’s most profitable transaction was an Informative Sell of ARVN stock on February 18, 2026. The return on the trade was 33.50%.
What is Andrew Saik's role in Arvinas Holding Company?
Andrew Saik's role in Arvinas Holding Company is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.